drugset / Trial / NCT02182245
Dose Escalation Study of BIBF 1120 in Patients With Advanced Gynaecological Malignancies
NaSingle-groupOpen-labelTreatment
Summary
The primary objectives of this trial were to determine the safety, tolerability, and MTD of BIBF 1120 when added to standard therapy with carboplatin and paclitaxel
Timeline
- Start
- 2005-10-01
- Primary completion
- 2007-01-01
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nintedanib | Small molecule | — | Oral |
| Background | Carboplatin | Small molecule | — | — |
| Background | Paclitaxel | Small molecule | — | — |